Blog - Page 2 of 13 - Patient Focused Medicines Development
Different patients, different solutions: PFMD at the EFGCP Annual Meeting

Danielle Barron speaks to PFMD co-founder Tony Hoos about his recent participation at the EFGCP Annual Conference in Brussels What is an acceptable level of uncertainty? What is an acceptable benefit/risk ratio? These questions and many others were asked during the European Forum of Good Clinical Practice 2019 annual conference. Held in Brussels in late February, the meeting sought to answer...

Read More